Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 3;9(9):1229.
doi: 10.3390/foods9091229.

Do Your Kids Get What You Paid for? Evaluation of Commercially Available Probiotic Products Intended for Children in the Republic of the Philippines and the Republic of Korea

Affiliations

Do Your Kids Get What You Paid for? Evaluation of Commercially Available Probiotic Products Intended for Children in the Republic of the Philippines and the Republic of Korea

Clarizza May Dioso et al. Foods. .

Abstract

A wide range of probiotic products is available on the market and can be easily purchased over the counter and unlike pharmaceutical drugs, their commercial distribution is not strictly regulated. In this study, ten probiotic preparations commercially available for children's consumption in the Republic of the Philippines (PH) and the Republic of Korea (SK) have been investigated. The analyses included determination of viable counts and taxonomic identification of the bacterial species present in each formulation. The status of each product was assessed by comparing the results with information and claims provided on the label. In addition to their molecular identification, safety assessment of the isolated strains was conducted by testing for hemolysis, biogenic amine production and antibiotic resistance. One out of the ten products contained lower viable numbers of recovered microorganisms than claimed on the label. Enterococcus strains, although not mentioned on the label, were isolated from four products. Some of these isolates produced biogenic amines and were resistant to one or several antibiotics. Metagenomic analyses of two products revealed that one product did not contain most of the microorganisms declared in its specification. The study demonstrated that some commercial probiotic products for children did not match their label claims. Infants and young children belong to the most vulnerable members of society, and food supplements including probiotics destined for this consumer group require careful checking and strict regulation before commercial distribution.

Keywords: children; label claims; lactic acid bacteria; molecular identification; probiotics; safety; viable count.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. This study was strictly for academic and informative purposes and not intended as quality control for any agency or company.

Figures

Figure 1
Figure 1
Quantitative label claims versus recovered CFUs from commercial probiotic products intended for children in the Republic of the Philippines (products A–E) and Republic of Korea (products F–J) (* p < 0.05).

Similar articles

Cited by

References

    1. Hyams J.S., Di Lorenzo C., Saps M., Shulman R.J., Staiano A., Van Tilburg M. Childhood Functional Gastrointestinal Disorders: Child/Adolescent. Gastroenterology. 2016;150:1456–1468. doi: 10.1053/j.gastro.2016.02.015. - DOI - PubMed
    1. O’Sullivan A., Farver M., Smilowitz J.T. Article Commentary: The Influence of Early Infant-Feeding Practices on the Intestinal Microbiome and Body Composition in Infants. Nutr. Metab. Insights. 2015;8:1–9. doi: 10.4137/NMI.S29530. - DOI - PMC - PubMed
    1. Schneider C., Illi M., Lötscher M., Wehrli M., Von Gunten S. Isolation of Antibodies from Human Plasma, Saliva, Breast Milk, and Gastrointestinal Fluid. In: Kaveri S.V., Bayry J., editors. Natural Antibodies. Volume 1643. Humana Press; New York, NY, USA: 2017. pp. 23–31. (Methods in Molecular Biology). - PubMed
    1. Canani R.B., Cirillo P., Terrin G., Cesarano L., Spagnuolo M.I., Vincenzo A.D., Albano F., Passariello A., Marco G.D., Manguso F., et al. Probiotics for treatment of acute diarrhoea in children: Randomised clinical trial of five different preparations. BMJ. 2007;335:340. doi: 10.1136/bmj.39272.581736.55. - DOI - PMC - PubMed
    1. Allen S.J., Martinez E.G., Gregorio G.V., Dans L.F. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst. Rev. 2010;11:1–96. doi: 10.1002/14651858.CD003048.pub3. - DOI - PMC - PubMed

LinkOut - more resources